India  

Oxford vaccine trial paused over side effects

IndiaTimes Wednesday, 9 September 2020 ()
AstraZeneca maintains that the exact nature of the illness is currently unknown and such pauses are common during the development of a vaccine.
0
shares
ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: India's drug firm Serum Institute gets notice after Oxford vaccine trial put on hold |Oneindia News

India's drug firm Serum Institute gets notice after Oxford vaccine trial put on hold |Oneindia News 01:15

The Serum Institute of India which is manufacturing the Oxford University's Covishield vaccine has been issued a showcause notice by the country's drug controller DGCI. Trials for the vaccine were stopped in four nations as a precautionary measure after one of the recipients in the UK showed some...

You Might Like


Related videos from verified sources

Doctor warns rushing for a COVID-19 vaccine could be dangerous, local volunteer encouraging push for cure [Video]

Doctor warns rushing for a COVID-19 vaccine could be dangerous, local volunteer encouraging push for cure

The race for a coronavirus vaccine is moving backward. At least for AstraZeneca and Oxford University, but doctors urge vaccine makers to take things slow.

Credit: WEWS NewsChannel5     Duration: 02:34Published
Mid-Morning Headlines From September 9, 2020 [Video]

Mid-Morning Headlines From September 9, 2020

The trial for a COVID-19 vaccine about to be tested on Minnesotans is now on pause and is being investigated for potentially serious side-effects (3:25). WCCO Mid-Morning - September 9, 2020

Credit: CBS 4 WCCO Minnesota     Duration: 03:25Published
AstraZenca pauses coronavirus vaccine trials [Video]

AstraZenca pauses coronavirus vaccine trials

One company has paused its trials for a coronavirus vaccine because of possible side effects. Astrazenca was in the late stages of its testing when a participant came down with some type of sickness.

Credit: KTNV Channel 13 Las Vegas     Duration: 00:22Published

Related news from verified sources

AstraZeneca COVID-19 vaccine trial on hold

AstraZeneca COVID-19 vaccine trial on hold
Late-stage studies of AstraZeneca's COVID-19 vaccine candidate, being developed by Oxford University, are on temporary hold while the firm investigates whether a...
Mid-Day

Vaccine may be ready by year-end

The trials of the COVID-19 vaccine, which is being jointly developed by the Oxford University and British-Swedish drug maker AstraZeneca were halted after a...
IndiaTimes


Tweets about this

driplikesake

Saketh Nimmagadda RT @MaxCRoser: When Oxford paused the vaccine trial last week it made front page news around the world (including entirely misleading ones… 2 hours ago

MarieAnneLeCler

Marie-Anne Le Clerc RT @MicrobesInfect: AstraZeneca resumed the clinical #COVID19 vaccine study they paused last week after a participant developed side effect… 2 hours ago

GuthrieAardvark

Richard RT @DelthiaRicks: Major Covid19 vaccine trial resumes in the UK after safety review. AstraZeneca & Oxford Univ said Saturday they had resum… 5 hours ago

Joliesoile

Sue Ellen Peters RT @LiveScience: Why AstraZeneca just paused its coronavirus vaccine trial https://t.co/WCUqoyIWlc https://t.co/De5ZC3avGl 10 hours ago

rapplerdotcom

Rappler Stoppages of clinical trials are a normal part of the testing process, and show that patient safety is being taken… https://t.co/PkC1uM7JcT 10 hours ago

Makedni

Pallas Athena RT @Makedni: “ A woman in the U.K showed neurological symptoms often associated with transverse myelitis, a condition where t spinal cord b… 12 hours ago

Makedni

Pallas Athena “ A woman in the U.K showed neurological symptoms often associated with transverse myelitis, a condition where t sp… https://t.co/9M9PWv8iVD 12 hours ago

PHLNewsInsider

PHL News Insider RT @rapplerdotcom: Stoppages of clinical trials are a normal part of the testing process, and show that patient safety is being taken serio… 13 hours ago